Literature DB >> 29206625

Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells.

Benedetto Sacchetti1, Alessandro Fatica2, Melissa Sorci2, Antonio Sorrentino3, Michele Signore4, Annamaria Cerio4, Federica Felicetti4, Alessandra De Feo4, Elvira Pelosi4, Alessandra Caré4, Edoardo Pescarmona5, Jan Oxholm Gordeladze6, Mauro Valtieri7.   

Abstract

MiR-204 and 211 enforced expression in murine mesenchymal stromal cells (MSCs) has been shown to induce adipogenesis and impair osteogenesis, through RUNX2 down-modulation. This mechanism has been suggested to play a role in osteoporosis associated with obesity. However, two further fundamental MSC functions, chondrogenesis and hematopoietic supporting activity, have not yet been explored. To this end, we transduced, by a lenti-viral vector, miR-204 and 211 in a model primary human MSC line, opportunely chosen among our MSC collection for displaying all properties of canonical bone marrow MSCs, except adipogenesis. Enforced expression of miR-204&211 in these cells, rescued adipogenesis, and inhibited osteogenesis, as previously reported in murine MSCs, but, surprisingly, also damaged cartilage formation and hematopoietic supporting activity, which were never explored before. RUNX2 has been previously indicated as the target of miR-204&211, whose down modulation is responsible for the switch from osteogenesis to adipogenesis. However, the additional disruption of chondrogenesis and hematopoietic supporting activity, which we report here, might depend on diverse miR-204&211 targets. To investigate this hypothesis, permanent RUNX2 knock-down was performed. Sh-RUNX2 fully reproduced the phenotypes induced by miR-204&211, confirming that RUNX2 down modulation is the major event leading to the reported functional modification on our MSCs. It seems thus apparent that RUNX2, a recognized master gene for osteogenesis, might rule all four MSC commitment and differentiation processes. Hence, the formerly reported role of miR204&211 and RUNX2 in osteoporosis and obesity, coupled with our novel observation showing inhibition of cartilage differentiation and hematopoietic support, strikingly resemble the clinical traits of metabolic syndrome, where osteoarthritis, osteoporosis, anaemia and obesity occur together. Our observations, corroborating and extending previous observations, suggest that miR-204&211-RUNX2 axis in human MSCs is possibly involved in the pathogenesis of this rapidly growing disease in industrialized countries, for possible therapeutic intervention to regenerate former homeostasis. © B. Sacchetti et al., published by EDP Sciences, 2017.

Entities:  

Year:  2017        PMID: 29206625     DOI: 10.1051/rmr/170004

Source DB:  PubMed          Journal:  Regen Med Res        ISSN: 2050-490X


  4 in total

1.  FOXP1 circular RNA sustains mesenchymal stem cell identity via microRNA inhibition.

Authors:  Alessandro Cherubini; Mario Barilani; Riccardo L Rossi; Murtadhah M K Jalal; Francesco Rusconi; Giuseppe Buono; Enrico Ragni; Giovanna Cantarella; Hamish A R W Simpson; Bruno Péault; Lorenza Lazzari
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

2.  LncRNA TUG regulates osteogenic differentiation of bone marrow mesenchymal stem cells via miRNA-204/SIRT 1.

Authors:  Xiao Ouyang; Yunzhi Ding; Li Yu; Feng Xin; Xiaowei Yang
Journal:  J Musculoskelet Neuronal Interact       Date:  2022-09-01       Impact factor: 1.864

Review 3.  Functional roles of circular RNAs during epithelial-to-mesenchymal transition.

Authors:  Bing-Qing Shang; Min-Le Li; Hao-Yu Quan; Ping-Fu Hou; Zhong-Wei Li; Su-Fang Chu; Jun-Nian Zheng; Jin Bai
Journal:  Mol Cancer       Date:  2019-09-16       Impact factor: 27.401

Review 4.  Small and Long Non-coding RNAs as Functional Regulators of Bone Homeostasis, Acting Alone or Cooperatively.

Authors:  Mateusz Sikora; Krzysztof Marycz; Agnieszka Smieszek
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-15       Impact factor: 8.886

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.